Head-to-head · WeighScore
Nolu vs REMEVi
By GLP-1 ScorecardUpdated
Score comparison
REMEVi has the higher recorded score — 73.5/100 to 69.7/100.
REMEVi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Nolu | REMEVi |
|---|---|---|
| WeighScore | 69.7/100 | 73.5/100 |
| Grade | C | C |
| Site position | #130 | #77 |
| Semaglutide | $249/mo injectable, $279/mo oral — billed per 4 weeks | $219/mo |
| Tirzepatide | $339/mo — billed per 4 weeks | $319/mo |
| Coverage | All 50 states plus Washington, D.C. | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #130 · C
Strengths
- All-in per-order pricing — consultation, medication and shipping in one figure, no separate membership fee
- Oral semaglutide ($279 per 4 weeks) alongside the injectable, plus a Microdose GLP-1+B12/NAD+ stack ($179 per 4 weeks)
- LegitScript verified, available in all 50 states plus Washington, D.C.
What to consider
- Billed "per 4 weeks" rather than calendar month — roughly 8% higher annualized than the $249/$339 headline implies
- No named medical director, prescribers, or compounding pharmacy disclosed anywhere on the site
- Compounded only — not the FDA-approved brand product (Wegovy/Ozempic), which matters if you're relying on insurance
Site position #77 · C
Strengths
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
- Available in all 50 states and DC, with no minimum commitment and no cancellation fee
What to consider
- The flat rate is the highest entry price of the top-scoring programs here; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.